Regulatory-arkiv - Page 2 of 12 - Egetis Therapeutics

21 February, 2019 Year-end Report January-December 2018 News English Regulatory MAR Report Interim Yearend IR Optional mfn-cus-aladote mfn-cus-pledox

31 January, 2019 Aladote®’s data has been selected for presentation at The International Liver Congress News English Regulatory IR Optional

17 January, 2019 PledPharma presents PledOx®’s phase III program at the Gastrointestinal (GI) Cancers Symposium News English Regulatory IR Optional

10 January, 2019 First Asian patient has been included in the global Phase III program for PledOx® and will trigger a milestone payment of 600 MJPY (c.49 MSEK) to PledPharma News English Regulatory IR Optional

24 December, 2018 PledPharma applies for an Orphan Drug Designation (ODD) in the US for Aladote News English Regulatory IR Optional

13 December, 2018 PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference News English Regulatory IR Optional

5 December, 2018 PledPharma prepares for listing on the Nasdaq Stockholm main market during 2019 News English Regulatory IR Optional

8 November, 2018 The first patient included in PledPharma’s global Phase III program for PledOx® News English Regulatory IR Optional

26 October, 2018 Nomination Committee appointed for the 2019 Annual General Meeting in PledPharma News English Regulatory IR Optional

23 October, 2018 Interim Report January-September 2018 News English Regulatory MAR Report Interim Q3 IR Optional

28 September, 2018 Study drug for the PledOx® global phase III program delivered News English Regulatory IR Optional

24 September, 2018 Pledpharma announces positive results from the Aladote® proof of principle study News English Regulatory IR Optional

22 August, 2018 Half-Year Report January-June 2018 News English Regulatory MAR Report Interim Q2 IR Optional

15 August, 2018 Delivery of study drug to the PledOx® phase III program is expected in September News English Regulatory IR Optional

24 April, 2018 Interim Report January-March 2018 News English Regulatory MAR Report Interim Q1 IR Optional

Press releases